EARNINGS: hVIVO CFO to retire; Personal Group sales and profit climb
15th Sep 2026 15:54
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 6.00p on 02-10-2026 at 18:35:12 |
|---|---|
| Change | -0.10p -1.64% |
| Buy | 6.10p |
| Sell | 5.90p |
| Last Trade: | Sell 61,710.00 at 5.95469p |
| Day's Volume: | 903,080 |
| Last Close: | 6.00p |
| Open: | 6.10p |
| ISIN: | GB00B9275X97 |
| Day's Range | 5.95p - 6.10p |
| 52wk Range: | 4.35p - 10.00p |
| Market Capitalisation: | £41.30m |
| VWAP: | 5.982001p |
| Shares in Issue: | 688.40m |
Sector: Health Care and Related Services
Listed In: FTSE AIM 100, FTSE AIM All-Share,
hVIVO (HVO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 61,710 | 5.95469p | Ordinary |
16:42:50 - 02-Oct-26 |
| Unknown* | 153 | 6.00p | Negotiated Trade |
16:36:02 - 02-Oct-26 |
| Buy* | 10,000 | 6.07p | Ordinary |
16:26:12 - 02-Oct-26 |
| Sell* | 20,000 | 5.91p | Ordinary |
15:51:23 - 02-Oct-26 |
| Sell* | 66,878 | 5.975p | Ordinary |
15:33:53 - 02-Oct-26 |
| Sell* | 30,000 | 5.92p | Ordinary |
15:29:29 - 02-Oct-26 |
| Sell* | 104,713 | 5.90p | Ordinary |
15:12:59 - 02-Oct-26 |
| Buy* | 100 | 6.10p | SI Trade |
14:39:57 - 02-Oct-26 |
| Buy* | 16,694 | 5.99p | Ordinary |
14:39:32 - 02-Oct-26 |
| Buy* | 4,090 | 5.99p | Ordinary |
14:36:31 - 02-Oct-26 |
hVIVO (HVO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Sep 2026 7:00 am | RNS | Board Changes |
| 15th Sep 2026 7:01 am | RNS | Interim Results |
| 15th Sep 2026 7:00 am | RNS | Chief Financial Officer Succession |
| 8th Sep 2026 3:51 pm | RNS | Holding(s) in Company |
| 4th Sep 2026 7:00 am | RNS | Notice of Results |
| 27th Aug 2026 7:00 am | RNS | hVIVO acquires CRS Berlin |
| 23rd Jul 2026 7:00 am | RNS | H1 2026 Trading Update |
| 13th Jul 2026 7:00 am | RNS | Change of Auditor |
| 9th Jun 2026 7:00 am | RNS | Holding(s) in Company |
| 1st Jun 2026 12:00 pm | RNS-R | Consultancy contract with Decoy Therapeutics |